The global cell culture market was estimated to be valued at US$ 15,805.7 million in 2019, and is expected to exhibit a CAGR of 7.2% over the forecast period (2019-2027), as highlighted in a new report published by Coherent Market Insights.
High prevalence of breast cancer is expected to propel growth of the global cell culture market over the forecast period. For instance, according to Breastcancer.org, in 2019, an estimated 268,600 new cases of invasive breast cancer were expected to be diagnosed in women in the U.S. along with 62,930 new cases of non-invasive (in situ) breast cancer. Moreover, increasing product launches is also expected to boost growth of the market. For instance, in October 2019, Thermo Fisher Scientific Inc. launched Cytomat 2 C-LiN Series Automated Incubator, which is designed to offer cell growth and environmental control across a range of micro plate applications that include cell-based screening, immuno-capture assays, microbiology, and enzyme testing.
Get PDF Brochure with Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/116
Investment in establishing new cell culture technology centers is expected to propel growth of the global cell culture market over the forecast period. For instance, in May 2019, Bayer AG announced to invest US$ 150 million in its pharmaceutical development and manufacturing site at Berkeley, CA, to build a Cell Culture Technology Center for R&D in biological therapies.
Browse 26 Market Data Tables and 20 Figures spread through 160 Pages and in-depth TOC on ‘Global Cell Culture Market, by Product Type (Instruments and Consumables), by Application (Vaccine Production, Gene Therapy, Cancer Research, Tissue Culture, Drug Development, and Others), by End User (Academic & Research Institutions, and Pharmaceutical and Biotechnology Companies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Global Forecast to 2027”
Among the product types, the consumables segment is expected to hold dominant position in the global cell culture market during the forecast period, owing to launch of new products. For instance, in March 2016, Lonza launched PowerCHO Advance media, a serum-free media for culturing Chinese Hamster Ovary (CHO) cells designed to offer improved cell-growth promotion and high protein titers.
Among end users, the pharmaceutical and biotechnology companies segment is expected to account for the largest market share in the global cell culture market over the forecast period. This is attributed to launch of new products. For instance, in May 2019, Thermo Fisher Scientific Inc. launched GIBCO CTS LV-MAX Lentiviral Production System, which is designed to produce high titer lentiviral vectors.
Get Sample Report with Latest Insights @ https://www.coherentmarketinsights.com/insight/request-sample/116
Major players in the market are focused on adopting collaboration and partnership strategies to expand their product portfolio. For instance, in June 2019, Thermo Fisher Scientific Inc. partnered with Scinogy, an automated manufacturing systems provider for cell therapies, for the development and commercialization of instrumentation and reagent systems designed to improve productivity and scalability of cell and gene therapy manufacturing.
Major players in the market are also focused on adopting M&A strategies to expand their product portfolio. For instance, in March 2019, Thermo Fisher Scientific Inc. entered into a definitive agreement with Brammer Bio, LLC, a provider of development and early phase to commercial GMP manufacturing services for cell and gene therapies, under which Thermo Fisher will acquire Brammer Bio for around US$ 1.7 billion in cash.
Key Takeaways
- The global cell culture market is expected to exhibit a CAGR of 7.2% over the forecast period
- High prevalence of breast cancer to augment growth of the global cell culture market over the forecast period
- Major players operating in the global cell culture market include, Corning Incorporated, Merck KGaA, Sartorius AG, BioSpherix, Ltd., Cell Culture Company, LLC, Thermo Fisher Scientific Inc., VWR International LLC, and Lonza
Purchase This Premium Report Here To Access Full Information @ https://www.coherentmarketinsights.com/insight/buy-now/116
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: [email protected]
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837